Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CollPlant Biotechnologies (CLGN) Profit After Tax (2017 - 2025)

CollPlant Biotechnologies filings provide 9 years of Profit After Tax readings, the most recent being $19.8 million for Q4 2025.

  • On a quarterly basis, Profit After Tax rose 609.82% to $19.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28.1 million, a 216.88% increase, with the full-year FY2025 number at $11.5 million, up 169.17% from a year prior.
  • Profit After Tax hit $19.8 million in Q4 2025 for CollPlant Biotechnologies, up from $3.5 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $19.8 million in Q4 2025 to a low of -$9.3 million in Q4 2023.
  • Median Profit After Tax over the past 5 years was $3.4 million (2025), compared with a mean of $2.0 million.
  • Biggest five-year swings in Profit After Tax: plummeted 254.13% in 2021 and later skyrocketed 609.82% in 2025.
  • CollPlant Biotechnologies' Profit After Tax stood at -$3.8 million in 2021, then decreased by 16.68% to -$4.4 million in 2022, then plummeted by 112.43% to -$9.3 million in 2023, then skyrocketed by 58.52% to -$3.9 million in 2024, then skyrocketed by 609.82% to $19.8 million in 2025.
  • The last three reported values for Profit After Tax were $19.8 million (Q4 2025), $3.5 million (Q3 2025), and $3.3 million (Q2 2025) per Business Quant data.